Kaleido Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
– COVID-19 Clinical Development Program Topline Data Readout of Multi-Center Study Expected in Q4 2020 –– Plan to Initiate New […]
AnPac Bio Announces Preliminary Results From Prospective Trials Indicating Early-Stage Cancer Screening Effectiveness
SAN JOSE, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]
Neuronetics Reports Second Quarter 2020 Financial and Operating Results
MALVERN, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on […]
Warner Music Group Corp. Reports Results For Fiscal Third Quarter Ended June 30, 2020
Digital revenue grew 11.1% or 13.4% in constant currencyTotal revenue was down 4.5% or 3.1% in constant currencyNet loss was […]
SilverSun Technologies Acquires Prairie Technology Solutions Group
EAST HANOVER, NJ, Aug. 04, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SilverSun Technologies, Inc. (NASDAQ: SSNT), a national provider […]
Eloxx Pharmaceuticals Receives U.S. Orphan Drug Designation for ELX-02 for the Treatment of Cystic Fibrosis
WALTHAM, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the […]
Lantronix Announces Fall Investor Conference Schedule
IRVINE, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Lantronix, Inc. (the “Company”) (Nasdaq: LTRX), a global provider of secure data access […]
Clearside Biomedical to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
ALPHARETTA, Ga., Aug. 04, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments […]
EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce U.S. Commercial Alliance for DEXYCU®
WATERTOWN, Mass. and NASHVILLE, Tenn., Aug. 04, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to […]
Arvinas Reports Second Quarter 2020 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Aug. 04, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biopharmaceutical company creating a new […]
